We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
SELLAS Life Sciences
SLS
$2.63B
| $542K | ﹤0.01% |
+128,110
| New | +$573K |
|
2002
CTS Corp
CTS
$1.81B
| $541K | ﹤0.01% |
+11,325
| New | +$568K |
|
2003
Liberty Live Group Series A
LLYVA
$9.37B
| $541K | ﹤0.01% |
+5,902
| New | +$518K |
|
|
RAPP
2004
Rapport Therapeutics
RAPP
$2.32B
| $539K | ﹤0.01% |
+17,240
| New | +$485K |
|
2005
Progyny
PGNY
$1.94B
| $538K | ﹤0.01% |
+31,690
| New | +$679K |
|
2006
Triumph Financial Inc
TFIN
$1.86B
| $538K | ﹤0.01% |
+9,012
| New | +$563K |
|
2007
OptimizeRx
OPRX
$160M
| $536K | ﹤0.01% |
+85,400
| New | +$793K |
|
2008
Harrow
HROW
$1.48B
| $536K | ﹤0.01% |
+15,202
| New | +$668K |
|
2009
Horizon Bancorp
HBNC
$1.05B
| $535K | ﹤0.01% |
+32,308
| New | +$553K |
|
2010
Lifestance Health
LFST
$4.79B
| $533K | ﹤0.01% |
+83,645
| New | +$582K |
|
2011
Lindblad Expeditions
LIND
$2.15B
| $530K | ﹤0.01% |
+30,621
| New | +$544K |
|
2012
HDFC Bank
HDB
$119B
| $529K | ﹤0.01% |
+21,265
| New | +$661K |
|
2013
Schneider National
SNDR
$6.38B
| $528K | ﹤0.01% |
+20,045
| New | +$555K |
|
2014
Nuvation Bio
NUVB
$2.28B
| $528K | ﹤0.01% |
+123,162
| New | +$686K |
|
|
SILA
2015
DELISTED
Sila Realty Trust
SILA
| $527K | ﹤0.01% |
+22,257
| New | +$546K |
|
2016
ICICI Bank
IBN
$105B
| $526K | ﹤0.01% |
+20,306
| New | +$595K |
|
|
KW
2017
DELISTED
Kennedy-Wilson Holdings
KW
| $525K | ﹤0.01% |
+48,488
| New | +$503K |
|
2018
Lindsay Corp
LNN
$1.16B
| $523K | ﹤0.01% |
+4,392
| New | +$557K |
|
2019
GlobalFoundries
GFS
$29.3B
| $523K | ﹤0.01% |
+11,752
| New | +$518K |
|
2020
Helix Energy Solutions
HLX
$1.55B
| $523K | ﹤0.01% |
+52,852
| New | +$450K |
|
2021
Taysha Gene Therapies
TSHA
$2.02B
| $522K | ﹤0.01% |
+116,691
| New | +$543K |
|
2022
Forum Energy Technologies
FET
$971M
| $521K | ﹤0.01% |
+8,883
| New | +$451K |
|
2023
Novavax
NVAX
$1.33B
| $520K | ﹤0.01% |
+63,935
| New | +$580K |
|
2024
Simply Good Foods
SMPL
$959M
| $520K | ﹤0.01% |
+36,259
| New | +$626K |
|
2025
Cars.com
CARS
$635M
| $519K | ﹤0.01% |
+63,892
| New | +$653K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.